HomeHealth
Health
Fastest Growing Company in Massachusetts Honored as 2024 BostInno Fire Award Honoree
Three-time honoree Uwill recognized for its growth, innovation, and success
NATICK, Mass., Oct. 11, 2024 /PRNewswire/ -- On the heels of World Mental Health Day, Uwill, the leading mental health and wellness solution, announced its recognition as a 2024 BostInno Fire Award Honoree. The recognition...
Pharmaceutical Filtration Industry Forecasts $18.1 Billion Market Size by 2029
Advancements in Filter Media and Smart Membrane Technologies Propel Pharmaceutical Filtration Market Growth Amid Biopharma Boom and Personalized Medicine Demand
BOSTON, Oct. 11, 2024 /PRNewswire/ -- "According to the latest BCC Research study, the demand for "Pharmaceutical Filtration: Global Markets" is estimated to grow from $11.4...
HealthCentral Wins Top Honors at MM&M Awards for Consumer, Professional Brands
Announced October 10 in New York City, the MM+M Awards recognize the most creative and effective healthcare marketing and communications platforms and campaigns in the industry.
"We are honored to receive awards this year for both our consumer and professional brands, including being the only...
Cardinal Health to acquire Integrated Oncology Network, a physician-led independent community oncology network
Transaction demonstrates Cardinal Health's continued strategic investment in specialty and oncology, underscores commitment to independent community healthcare providers
Accelerates the development of Navista oncology practice alliance, adding more than 100 providers at more than 50 community-based sites delivering broad-reaching oncology and urology care across 10 states
DUBLIN,...
Kintara Therapeutics Announces Adjournment of Special Meeting of Stockholders until October 4, 2024
SAN DIEGO, Sept. 20, 2024 /PRNewswire/ -- Kintara Therapeutics, Inc. (Nasdaq: KTRA) ("Kintara"), a biopharmaceutical company focused on the development of new solid tumor cancer therapies, today announced it adjourned the Special Meeting of Stockholders (the "Special Meeting") held on September 20, 2024. The...
Health Canada Approves CardioFlux MCG for the Diagnosis of Myocardial Ischemia
Newly announced Canadian license marks the first approval of any kind of MCG device in Health Canada history
MASON, Ohio, Sept. 20, 2024 /PRNewswire/ -- Genetesis, Inc., a leader in the field of magnetocardiography (MCG), today announced that Health Canada has approved the CardioFlux Magnetocardiograph with...
- Advertising -
- Advertising -
- Advertising -
- Advertising -